Phase 3 Heart Diseases Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

CardiomyopathiesAmyloidosisHeart Diseases+3 more

Eidos Therapeutics, a BridgeBio company582 enrolled98 locationsNCT06563895

Recruiting

Phase 3

Lumason® Infusion vs. Bolus Administrations

Heart Diseases

Bracco Diagnostics, Inc106 enrolled6 locationsNCT06400004